| __timestamp | Amicus Therapeutics, Inc. | Bio-Techne Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 47624000 | 30945000 |
| Thursday, January 1, 2015 | 76943000 | 40853000 |
| Friday, January 1, 2016 | 104793000 | 45187000 |
| Sunday, January 1, 2017 | 149310000 | 53514000 |
| Monday, January 1, 2018 | 270902000 | 55329000 |
| Tuesday, January 1, 2019 | 286378000 | 62413000 |
| Wednesday, January 1, 2020 | 308443000 | 65192000 |
| Friday, January 1, 2021 | 272049000 | 70603000 |
| Saturday, January 1, 2022 | 276677000 | 87140000 |
| Sunday, January 1, 2023 | 152381000 | 92493000 |
| Monday, January 1, 2024 | 96664000 |
Cracking the code
In the ever-evolving biotech industry, research and development (R&D) expenses are a critical indicator of a company's commitment to innovation. Over the past decade, Amicus Therapeutics, Inc. and Bio-Techne Corporation have demonstrated contrasting R&D investment strategies. From 2014 to 2023, Amicus Therapeutics increased its R&D spending by over 220%, peaking in 2020. This surge underscores their aggressive pursuit of groundbreaking therapies. In contrast, Bio-Techne Corporation exhibited a steady growth in R&D expenses, with a 200% increase over the same period, reflecting a more measured approach to innovation.
Interestingly, 2023 saw a significant drop in Amicus's R&D expenses, while Bio-Techne continued its upward trend. This divergence may signal strategic shifts within these companies. As we look to 2024, Bio-Techne's consistent investment suggests a continued focus on expanding its product pipeline, while Amicus's strategy remains to be seen.
Comparing Innovation Spending: Novartis AG and Bio-Techne Corporation
Who Prioritizes Innovation? R&D Spending Compared for Pfizer Inc. and Amicus Therapeutics, Inc.
Research and Development Expenses Breakdown: Neurocrine Biosciences, Inc. vs Amicus Therapeutics, Inc.
Research and Development Expenses Breakdown: Bio-Techne Corporation vs BioMarin Pharmaceutical Inc.
R&D Insights: How Bio-Techne Corporation and Lantheus Holdings, Inc. Allocate Funds
Research and Development Investment: Bio-Techne Corporation vs CRISPR Therapeutics AG
Research and Development Expenses Breakdown: Bio-Techne Corporation vs Perrigo Company plc
Research and Development Expenses Breakdown: Bio-Techne Corporation vs Travere Therapeutics, Inc.
R&D Insights: How Jazz Pharmaceuticals plc and Amicus Therapeutics, Inc. Allocate Funds
Analyzing R&D Budgets: Grifols, S.A. vs Amicus Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Amicus Therapeutics, Inc. and Ligand Pharmaceuticals Incorporated
Who Prioritizes Innovation? R&D Spending Compared for Amicus Therapeutics, Inc. and Soleno Therapeutics, Inc.